Our findings demonstrate an immunological dysregulation in patients with allergic conjunctivitis, characterized by the low expression of IL-10 in circulating CD19+CD38+ Bregs subsets, and an inverted tear IL-10/TNF-α ratio. The gene discussed is CD19; the disease is atopic conjunctivitis.